Corrigendum to “Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells” [Toxicol. Lett. 179 (June(2)) (2008) 63–70]
2008; Elsevier BV; Volume: 181; Issue: 2 Linguagem: Inglês
10.1016/j.toxlet.2008.07.012
ISSN1879-3169
AutoresShu-Jun Chiu, Jie Chao, Yong J. Lee, Tzu-Sheng Hsu,
Tópico(s)Hepatocellular Carcinoma Treatment and Prognosis
ResumoThe authors regret that they have incorrectly cited a recent publication in Cancer Treatment Reviews entitled “Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review”, Stordal, B., Pavlakis, N., Davey, R., 2007. Cancer Treatment Reviews 33(4), 347–357, and have significantly misrepresented the Stordal et al. findings. To correct the error will require the removal of one sentence from the introduction and one sentence from the Discussion. In the Introduction, on the first page, the fourth line, the following sentence should be removed “Oxaliplatin has been widely accepted as potentially useful for the treatment of cisplatin-resistant cancer (Stordal et al., 2007).” In the Discussion, on the fifth page, 2nd paragraph, third line, the following sentence should be removed “Oxaliplatin has been reported to be useful for the treatment of cisplatin-resistant cancer (Stordal et al., 2007).” The authors of the cited article have also provided a Letter to the Editor that explains their view.
Referência(s)